baber/WOPTO huggingface dataset:
Patent EP-1287769-A2 (EP)
Inventor: TIEDEMANN ROMAN
IPC: G09F1/10
Filed: 2002-08-29
Abstract: Suspension unit for a profile rail (1) comprises a suspension element (16) which takes the form an elastic bow provided with a suspension tab (19), and is insertable into the undercut groove (4) of the profile rail in such a way that it is pressed against the opposing wall elements (20, 21) of the groove.
Patent EP-1395680-A2 (EP)
Inventor: MOORE RACHAEL
IPC: C12Q1/68
Filed: 2002-05-15
Abstract: The invention provides a method for the detection of a polymorphism in OATPB in a human which method comprises determining the sequence of the human at one of the following positions: position (1113) of SEQ ID NO: 4 and/or position (312) of SEQ ID NO: 5. The polymorphism at position (1113) is presence of G and/or A and the polymorphism at position (312) is presence of Arg and/or Gln. The method for detection of a nucleic acid polymorphism is selected from amplification refractory mutation system and restriction fragment length polymorphism. The invention also provides use of the method to assess the pharmacogenetics of a drug transportable by OATB.
Patent EP-1372748-A2 (EP)
Inventor: DALAL PARESH S
IPC: A61L27/00
Filed: 2002-02-26
Abstract: A porous β-tricalcium phosphate material for bone implantation is provided. The multiple pores in the porous TCP body are separate discrete voids and are not interconnected. The pore size diameter is in the range of 20-500 μm, preferably 50-125 μm. The porous β-TCP material provides a carrier matrix for bioactive agents and can form a moldable putty composition upon the addition of a binder. Preferably, the bioactive agent is encapsulated in a biodegradable agent. The invention provides a kit and an implant device comprising the porous β-TCP, and a bioactive agent and a binder. The invention also provides an implantable prosthetic device comprising a prosthetic implant having a surface region, a porous β-TCP material disposed on the surface region and optionally comprising at least a bioactive agent or a binder. Methods of producing the porous β-TCP material and inducing bone formation are also provided.
Patent EP-1416887-A2 (EP)
Inventor: PLOUHAR PAMELA LYNN
IPC: C12N5/08
Filed: 2002-07-15
Abstract: L'invention concerne un procédé qui permet de réparer un défaut du tissu cartilagineux, un dispositif de réparation du cartilage (20) et un procédé de fabrication dudit dispositif de réparation du cartilage. Dans le procédé selon l'invention, un dispositif comprenant un échafaudage, par exemple, un matériau matriciel extracellulaire, est implanté dans le défaut et un lubrifiant biologique (234) est administré au défaut. Ce dispositif (20) comprend un échafaudage (100), par exemple un matériau matriciel extracellulaire naturel, et un lubrifiant biologique (234).
Patent EP-1421630-A2 (EP)
Inventor: KROLL ULRICH
IPC: H01L31/075
Filed: 2002-08-23
Abstract: The invention relates to a method of depositing a transparent conductive oxide layer (12) on a tempered glass substrate (10) which is disposed inside a chamber (26).  The inventive method consists in: providing sources (32, 34, 36) which contain an oxygen-based liquid compound, a liquid compound of the metal that is intended to form the oxide and a gas or liquid dopant respectively; establishing a temperature of between 130 and 300  DEG C and pressure of between 0.01 and 2 mbar in the chamber; and putting the sources in communication with said chamber.  In this way, the liquids are vaporised at the surface thereof, sucked into the chamber without any need for a carrier gas and made to react with the dopant such that the oxide layer forms on the substrate.
Patent EP-1385525-A2 (EP)
Inventor: HOFMANN ROBERT F
IPC: A61K31/12
Filed: 2002-03-22
Abstract: La présente invention concerne une formulation pharmaceutique, sa méthode de préparation, et son utilisation. Ladite formulation pharmaceutique contient des espèces peroxydiques ou des produits réactionnels résultant de l'oxydation d'un alcène, tel que le géraniol, par un agent d'oxydation contenant de l'oxygène tel que l'ozone; un solvant pénétrant, tel que le diméthyl sulfoxide; un colorant contenant un métal chélaté, tel que l'hématoporphyrine; et un composé d'oxydo-réduction aromatique, tel que la benzoquinone. Ladite formulation pharmaceutique est utilisée pour le traitement de chevaux atteints par des infections protozoaires de Sarcocyste.
Patent EP-1412287-A2 (EP)
Inventor: PAPARATTO GIUSEPPE
IPC: B01J31/06
Filed: 2002-07-30
Abstract: The present invention relates to a catalyst consisting of: (a) one or more metals of the platinum group as active components; (b) one or more polyolefins; and (c) a carrier. The invention also relates to a process for the synthesis of hydrogen peroxide (H<SUB>2</SUB>O<SUB>2</SUB>) from hydrogen and oxygen which uses said catalyst and the use of the hydrogen peroxide solution in oxidation processes catalyzed by titanium silicalite. The process operates under high safety conditions with a high productivity and molar selectivity towards the formation of H<SUB>2</SUB>O<SUB>2</SUB>.
Patent EP-1425805-A2 (EP)
Title: Piezoelectric motor comprising copper electrodes
Inventor: MAGNUSSEN BJOERN
IPC: H01L41/047
Filed: 2002-08-26
Abstract: The invention relates to a piezoelectric motor comprising at least one piezoelectric component having a monolithic multilayer construction. Said component consists of a pile of at least two ceramic layers and respectively of one electrode layer which is arranged between two ceramic layers and contains copper.
Patent EP-1448208-A2 (EP)
Inventor: EYMARD MICHELE
IPC: A61K31/58
Filed: 2002-11-18
Abstract: The invention concerns compositions useful in therapeutics and in cosmetology. The composition comprises a diosgenin ester with linear or branched alkylated ester chain containing 1 to 30 carbon atoms selected preferably among diosgenin lactate and glycalate. The invention is applicable in dermatology by acting on the superficial musculo-aponevrotic system or on estrogen and progestenone cell receptors.
Patent EP-1463613-A2 (EP)
Inventor: SANCHEZ DAN
IPC: A61B19/00
Filed: 2002-12-04
Abstract: A handle (32) used to control movement of a medical instrument (50). The medical instrument (50) may be coupled to a robotic arm (12) that is connected to a controller (22). The medical instrument may have a plurality of functions such as wrist locking (132) and motion scaling (134). One of the functions may be selected through a graphical user interface (130) operated by the end user. The handle may have a plurality of buttons (116, 118, 120). One of the buttons may allow the end user to control the selected function. For example, when wrist locking/unlocking is selected, depressing the button can toggle the medical instrument wrist between a locked state and an unlocked state.
Patent EP-1449162-A2 (EP)
Inventor: MAUTZ KARL
IPC: H01L21/00
Filed: 2002-09-12
Abstract: L'invention concerne une plaquette de semiconducteur (10), un procédé pour placer des informations sur une plaquette de semiconducteur (10), un système comprenant une plaquette de semiconducteur (10) et un moyen de lecture, ainsi qu'un procédé pour lire des informations sur une plaquette de semiconducteur (10). L'invention se caractérise en ce que le support d'information est un moyen magnétique (14), des capteurs magnétiques (26) correspondants étant utilisés pour lire ce type d'information.
Patent EP-1434885-A2 (EP)
Inventor: CARROLL JOSEPH M
IPC: A61K39/395
Filed: 2002-10-08
Abstract: La présente invention porte sur des molécules d'acides nucléiques isolées, appelées molécules d'acides nucléiques 21132, qui codent de nouveaux membres de la famille des récepteurs couplés à la protéine G (GPCR). Cette invention concerne également des molécules d'acides nucléiques antisens, des vecteurs d'expression de recombinaison contenant les molécules d'acides nucléiques 21132, des cellules hôtes dans lesquelles les vecteurs d'expression ont été introduits et des animaux transgéniques non humains dans lesquels un gène 21132 a été introduit ou dissocié. Cette invention porte en outre sur des protéines 21132 isolées, des protéines hybrides, des peptides antigéniques et des anticorps anti-21132. Cette invention porte enfin sur des méthodes diagnostiques et thérapeutiques faisant appel aux compositions de la présente invention.
Patent EP-1444265-A2 (EP)
Inventor: CRUZ TONY
IPC: A61K38/17
Filed: 2002-10-15
Abstract: The present invention provides compositions and methods for treating disorders associated with a response-to-injury process or proliferating cells in a mammal. These tissue disorders are associated with a novel cellular phenotype designated as 'transition cells' which are described herein, This cellular phenotype is characterized in having an activated erk kinase signaling activity, a stimulated AP-l binding activity, and at least one characteristic selected from the group consisting of: (a) increased podosome formation, (b) increased flux of intracellular or extracellular hyaluronans or hyaladherins, (c) increased expression of a hyaladherin, (d) an inability to form focal adhesions, (e) increased metalloproteinase activity, and (f) increased expression of a hyaladherin. Example of disorders include multiple sclerosis, diabetes mellitus and restenosis. The methods provided herein include administering to the mammal, an effective amount of a composition that alters the activity of transition molecules within a cell Transition molecules are shown to be comprised of hyaladherins, hyaluronans and associated molecules that regulate the transitional phenotype. A novel cell culture comprising transition cells is also provided, as well as compositions comprising particular peptides, polypeptides, and antibodies that affect the transitional phenotype.
Patent EP-1463800-A2 (EP)
Title: Precurseurs de chondrocytes derives de cellules souches embryonnaires humaines
Inventor: THIES R SCOTT
IPC: A61K35/12
Filed: 2002-12-06
Abstract: L'invention concerne un système permettant d'obtenir des cellules à partir d'une lignée de chondrocytes par le biais d'une différentiation de cellules souches pluripotentes de primate. Ce procédé consiste à cultiver les cellules en tant que micromasse ou sous une autre forme d'agrégat, dans un cocktail d'agents de différentiation permettant de faciliter la croissance du type de cellule voulu. La descendance permet de synthétiser de l'aggrécan ou du collagène de type II, ou d'autres produits caractéristiques de la lignée de chondrocytes. Les chondrocytes et les cellules précurseurs de chondrocytes obtenus selon l'invention sont adaptés à une utilisation à la fois dans le domaine de la recherche et dans le domaine de la thérapie clinique.
Patent EP-1332811-A2 (EP)
Inventor: HAURI ROLAND
IPC: B22D11/00
Filed: 2003-01-09
Abstract: Molding tube has a double T-shaped inner and outer cross-section in a beam-blank format surrounded by a water-deviating casing (12) fitting the outer contour and forming a water gap (14). The wall thickness of the molding tube is dimensioned by central bars (4) on a slanted flange (5). Preferred Features: The wall thickness is reduced in transition regions (2) only at the height of the bath meniscus. Recesses (8) are provided on the outer side of the transition regions. Several grooves are provided on the outer side of the transition regions. Bores are provided in the wall sections of the transition regions.
Patent EP-1333496-A2 (EP)
Inventor: SUDA TOSHIO
IPC: H03K19/003
Filed: 2003-01-16
Abstract: A switching device for switching a plurality of RF signal
lines (51, 52, 61, 62) to deliver a selected one of the RF signals to
a receiver (80, 81) has an isolation D/U characteristic as high as
40 dB or higher. The switching device 100 includes a mounting
board (40) made of dielectric and a matrix switch mounted
thereon and implemented by one or more of SWIC (10, 11. The
RF signal lines (51, 52, 61, 62) in the switching device has no
crossing point therebetween on either side of the mounting board
(40) to achieve the high isolation D/U ratio or lower cross-talk.
Patent EP-1343233-A2 (EP)
Inventor: SATO JUNICHI
IPC: H01H33/66
Filed: 2003-03-05
Abstract: The present invention provides a switch gear that can be easily introduced. A switch gear according to the present invention comprises a plurality of components (1a and 2) respectively including a switch gear constituting equipment, an insulating section to insulate the switch gear constituting equipment, and a joining section to join the switch gear constituting equipment in a vertical direction. The components (1a and 2) are jointed together in the vertical direction.
Patent EP-1329748-A2 (EP)
Inventor: NOGUCHI TAKANOBU
IPC: G02B5/30
Filed: 1995-11-09
Abstract: The present invention provides an optically
anisotropic film characterized in that the retardation
at 80°C is 20-97% of that at 30°C, and the film is made
from a mixture of a transparent or semitransparent
polymer and at least one liquid crystal compound,
wherein the ratio of the liquid crystal compound in the
mixture is 0.5-50% by weight based on the combined
weight of the liquid crystal compound and the polymer,
or an optically anisotropic film characterized in that
the retardation at 60°C is 50-99% of that at 30°C, and
the film comprises a mixture of a transparent or
semitransparent polymer and at least one liquid crystal
compound, wherein the ratio of the liquid crystal
compound in the mixture is 0.5-50% by weight based on
the combined weight of the liquid crystal compound and
the polymer. These optically anisotropic films have a
temperature dependence of retardation corresponding to
that of the liquid crystal display cell used in combination
with the film, show a temperature compensating
effect, and are also excellent in viewing angle
characteristics and display performance, so that they
can be used for the production of composite optically
anisotropic films or liquid crystal display devices.
Patent EP-1347306-A2 (EP)
Inventor: MATSUI SADANORI
IPC: G01S13/931
Filed: 2002-11-07
Abstract: A scan type radar device (10) capable of detecting a
lateral position of a target, even if a peak showing the
lateral position of the target irregularly fluctuates in
the lateral direction, as well as reducing the mis-pairing.
The former is achievable by changing a reference
value of the lateral fluctuation of the target when all
the past and present target data fluctuate to an extent
exceeding the reference value. The latter is achievable
by forecasting a representative peak position at this
time in both of up-beat and down-beat from the peak
position data at the preceding time and carrying out the
past-correspondence grouping of the up-beat and the down-beat
at this time in the vicinity of the position of the
representative peak forecast this time; the pairing being
carried out by using the representative peak calculated
by the past-correspondence grouping.
Patent EP-1410834-A2 (EP)
Inventor: SACCANI CESARE
IPC: B01D53/12
Filed: 2003-10-02
Abstract: Plant for the hot treatment of waste gases from
municipal waste incinerators or the like, comprising
a first line (6) of taking up hot waste gases for
treating in an exit section of a municipal waste
incinerator, a one stage or multiple stage fluid bed
(23, 30, 35) contained within one or several reactors
(8, 9) and invested by the waste gases to be treated,
at least one hopper (24, 34) for charging the solid
granular material into the reactor or reactors (8,
9), a cyclone separator (10) at the outlet of the
reactor or of the last of the reactors (8, 9); the
treated waste gases exiting from the reactor or
reactors (8, 9) being first introduced into said
separator (10) and subsequently conveyed, by said
first uptake line (6), toward a final discharge
chimney (5); said first uptake line (6) providing,
downstream of said cyclone separator (10), a second
recirculating line (15) moving the waste gases
treated by the reactor or reactors (8, 9), upstream
of the reactor or of the first of the reactors (8,
9), so that by this second line (15) said treated
waste gases mix with the waste gases to be treated
originating from the uptake section (1) of the
incinerator
Patent EP-1418414-A2 (EP)
Inventor: VOGT SEBASTIAN DIPL-ING
IPC: F16F15/32
Filed: 2003-11-03
Abstract: A friction clutch pressure plate (10) balancing procedure uses a housing (12) with flat balance weights (30) riveted in the connection bolt (20) support bar (16) areas (18) with temporary retention using clips or glue and dimensions chosen to suit the measured imbalance.
Patent EP-1432290-A2 (EP)
Inventor: OGASAWARA TAKAYUKI
IPC: G03G15/20
Filed: 2003-11-20
Abstract: An induction heating roller device that keeps leakage
current within specifications and prevents the occurrence of
erroneous operations caused by common mode noise. The
induction heating roller device includes an induction coil
(1), a grounded heating roller (2) magnetically coupled to
the induction coil and heated by electro-magnetic induction.
A power factor improving capacitor (3) is connected in
parallel to and near the induction coil and has a grounded
intermediate point. A high-frequency power source (4)
biases the induction coil. The leakage current produced by
distributed capacitance between the induction coil and the
heating roller is returned to the high-frequency power
source via the power factor improving capacitor. Thus, the
leakage current does not flow out of the induction heating
roller device.
Patent EP-1437303-A2 (EP)
Inventor: FERBER INGO
IPC: B31B50/62
Filed: 2003-12-19
Abstract: As hot-melt glue is transferred onto a length of fabric for blanks, transfer of glue depends on the speed at which the length of fabric is feed through and on other parameters. Glue pressure applied to the glue is controlled in accordance with the movement of the length of material to be glued. This is done via a pressure control valve (37) linked to a central machine controller (31).  An Independent claim is also included for a device for applying hot-melt glue/adhesive on a packaging production line.
Patent EP-1351333-A2 (EP)
Inventor: AUVRAY GERARD
IPC: H01Q3/30
Filed: 2003-04-01
Abstract: The multibeam adaptive antenna has a beam structure made up of clusters (31). A cluster is made up of a number of T/R modules. There is a combiner circuit assembly fed by the T/R modules. The number of circuit combiners is equal to the number of antenna beams formed.
Patent EP-1464583-A2 (EP)
Inventor: DRAGHETTI FIORENZO
IPC: B65B19/20
Filed: 2003-11-24
Abstract: A method and machine (1) for producing a package (2)
of tobacco articles complete with a folded coupon (5),
whereby a flat strip (12) is unwound off a reel (13) and
fed to a folding station (14) where the strip (12) is
folded over along at least one fold line (15) parallel to
the travelling direction of the strip (12); the folded
strip (12) is then fed to a cutting station (16), where
the folded strip (12) is cut along a cutting line
crosswise to the travelling direction of the strip (12)
to detach from the strip (12) the folded coupon (5),
which is engaged by a gripping head (10) cooperating with
the cutting station (16), and is fed to a seat (7) on a
packing conveyor (6) and onto a packet (3, 4) of tobacco
articles carried by the seat (7).
Patent EP-1341076-A2 (EP)
Inventor: EDMONDS JONATHAN A
IPC: B41J29/38
Filed: 2003-02-17
Abstract: A system includes a printer (20) having at least one
container (22) for storing a consumable and a monitor (26)
for monitoring the status of the consumable in the at least
one container; a host device (30) for sending a print job
to the printer, wherein the host device includes a display
(36); and a printer driver (32) for controlling operation
of the printer (20) from the host device, for querying the
printer for consumable status information, and for
providing a user interface in the host device display;
wherein the printer driver, responsive to the print job,
queries the printer for consumable status information and
displays the status of the consumable in the at least one
container in the printer in the user interface.
Patent EP-1349103-A2 (EP)
Inventor: ADAMIC LADA A
IPC: G16B50/00
Filed: 2003-03-25
Abstract: A method (200) of finding genes associated with a diseases, includes:
finding (205) all potential gene symbols; folding (210) at least one alias into
official gene symbols; and computing (215) the relevance of each official symbol
to the disease. The method may further include, eliminating (220) non-gene
symbols by use of contextual clues.
Patent EP-1495127-A2 (EP)
Inventor: EITEMAN MARK A
IPC: C12P7/22
Filed: 2003-02-20
Abstract: Microbial production of pyruvate and metabolites derived from pyruvate in cells exhibiting reduced pyruvate dehydrogenase activity compared to wild­type cells. Acetate and glucose are supplied as a carbon sources.
Patent EP-1495078-A2 (EP)
Inventor: TAKASE HIDEAKI
IPC: C09D4/00
Filed: 2003-03-11
Abstract: L'invention concerne une composition de résine photodurcissable qui renferme: (A) (A1) un (méth)acrylate dont la structure est représentée par la formule (1) ou (2), ou (A2) un composé époxy dont la structure est représentée par la formule (1) ou (2); (B) un (méth)acrylate ayant trois ou plus de trois groupes fonctionnels autres que (A1); (C) un photoamorçeur radicalaire; (D) un composé ayant trois ou plus de trois liens éther dans la molécule autres que (A2); et (E) un photoamorçeur cationique. L'invention concerne également des composants optiques réalisés à partir des résines décrites, et l'utilisation de ce type de résine dans d'autres applications.
Patent EP-1501998-A2 (EP)
Title: Fenetre resistant au souffle
Inventor: CODDENS DONALD L
IPC: E06B3/26
Filed: 2003-04-21
Abstract: Cette invention a trait à un ensemble fenêtre résistant au souffle. Cet ensemble se compose d'une fenêtre et de deux équerres. La fenêtre est installée dans une ouverture ménagée dans au moins une paroi. La première équerre est pourvue d'une entretoise contiguë à la fenêtre ainsi que d'une butée contiguë à la paroi. La seconde équerre, qui est contiguë à la paroi, est conçue pour recevoir la butée. En cas d'explosion, la force produite repousse la fenêtre contre l'entretoise de la première équerre, ce qui renvoie la butée vers la seconde équerre.
Patent EP-1488313-A2 (EP)
Inventor: ERLINGSSON ULFAR
IPC: G09G5/00
Filed: 2003-03-03
Abstract: L'invention concerne un procédé et un système de dénotation assurée d'une sémantique d'application ('ADAS'). Dans un système opérationnel exécutant au moins une application, on met en oeuvre un procédé offrant une dénotation assurée d'une sémantique d'application associée à l'application. On reçoit une opération graphique pour l'application qui comporte au moins un argument qui est intercepté pour l'opération graphique et modifié afin d'indiquer au moins une sémantique d'application associée à l'application.
Patent EP-1551497-A2 (EP)
Inventor: ATLANTIC MEDICAL INC
IPC: A61N1/36
Filed: 2003-06-10
Abstract: Cette invention concerne un dispositif électrique de stimulation nerveuse transcutanée (10) et une méthode d'utilisation d'un microcourant avec signal porteur et onde carrée destinés à promouvoir la réparation et/ou la cicatrisation cellulaire. On a constaté que l'application de formes d'onde particulières de courant continu à intervalles spécifiés favorisait la cicatrisation cellulaire, en particulier dans le traitement de la dégénérescence maculaire. Ce dispositif de stimulation nerveuse électrique (10) n'exige aucune entrée de la part de l'utilisateur, qui se contente d'appliquer les électrodes (22, 22A) à un emplacement approprié du corps et de lancer une séquence pré-programmée de courants électriques. La méthode consiste à appliquer des décharges de courant continu à hautes fréquences pendant de brefs laps de temps suivies décharges de courant continu à des fréquences plus basses, et pendant des laps de temps plus longs.